Merck
MRK
#41
Rank
C$472.68 B
Marketcap
C$191.74
Share price
0.73%
Change (1 day)
43.65%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$1.41

According to Merck's latest financial reports the company's current EPS (TTM) is C$1.42. In 2025 the company made an earnings per share (EPS) of C$10.48 an increase over its 2024 EPS that were of C$9.69.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.41-86.56%
2025C$10.488.15%
2024C$9.694308.46%
2023C$0.22-97.32%
2022C$8.2110.92%
2021C$7.4084.68%
2020C$4.01-27.2%
2019C$5.5163.44%
2018C$3.37151.11%
2017C$1.34-54.58%
2016C$2.9530.21%
2015C$2.27-61.99%
2014C$5.97180.51%
2013C$2.13-31.82%
2012C$3.126.62%
2011C$2.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$3.88 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.27 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.91 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.48 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.12 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.64-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel